Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 0CRN540O4R

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Tumor necrosis factor receptor superfamily member 4 antagonist Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 2 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594546
FDA SRS 0CRN540O4R